 - Therapy with any systemic anti-viral, anti-neoplastic or immunomodulatory treatment 6 months prior to the first dose of study drug and during study period. Exception: patients who have had a limited 7 days course of acyclovir or valacyclovir for herpetic lesions 1 month prior to the first administration of test drug are not excluded. 